El análisis funcional de una deleción cromosómica asociada a la esquizofrenia apunta a la cambios en la función de las mitocondrias como implicados en la enfermedad.
Read moreUn equipo de investigadores de la Universidad de Bristol, en Reino Unido, ha desarrollado una terapia génica con potencial para el tratamiento de pacientes con síndrome nefrótico con mutaciones en ...
Read moreCurrently, lymphoma accounts for 4% of all new cancer cases in Spain. It is rare compared to the most common cancers. However, there are many questions surrounding lymphoma and, above all, its treatme...
Read moreA study led by the Institute of Bioengineering of Catalonia demonstrates that laminin, a protein present in breast tissues, prevents the effects of stiffening, protecting cells against tumor growth. W...
Read moreThe findings support the hypothesis that fluctuating hormones, mainly estrogens, are related to changes in the human brain structure, but what is yet to be determined is how this influences neuroplast...
Read moreIt has been developed a new model of Alzheimer's disease to address the role of one of its risk factors: herpes virus. The results, published in the journal Microorganisms , determine the usefulness o...
Read moreIBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal p...
Read moreA study led by the Disease Biomarkers and Molecular Mechanisms Research Group (DIBIOMEC) of the Institut d’Investigació Sanitària Pere Virgili (IISPV) and in collaboration with the Rheumatology Se...
Read moreInvestigadores de la Universidad Duke han desarrollado una prueba para detectar la enfermedad de Parkinson basada en medir los daños en el ADN mitocondrial en sangre periférica. Una vez optimizada, ...
Read moreA team from the University of Barcelona has described how the lack of the CERKL gene alters the ability of retinal cells to fight oxidative stress generated by light and triggers cell death mechanisms...
Read more3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.
Read moreLa administración de rituximab en combinación con quimioterapia ha mejorado de forma significativa la tasa de supervivencia en pacientes pediátricos niños y adolescentes con linfoma no Hodgkin de ...
Read more